Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels
Bruno Lopes Santos‐Lobato, Mariza Bortolanza, Lucas C. Pinheiro, Marcelo E. Batalhão, Ângela Vieira Pimentel, Evelin Capellari-Carnio, Elaine A. Del-Bel, Vítor Tumas
Topics & Concepts
Nitric oxideNitriteCerebrospinal fluidPathophysiologyParkinson's diseaseNitrateInternal medicineLevodopaNeurologyMedicineAnesthesiaGastroenterologyEndocrinologyDiseaseChemistryPsychiatryOrganic chemistryParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsAmyotrophic Lateral Sclerosis Research